Health House International Ltd
ASX:HHI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Health House International Ltd
Free Cash Flow
Health House International Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Health House International Ltd
ASX:HHI
|
Free Cash Flow
-AU$4.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Paragon Care Ltd
ASX:PGC
|
Free Cash Flow
-AU$24.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-23%
|
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Free Cash Flow
AU$541.3m
|
CAGR 3-Years
72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
36%
|
|
Health House International Ltd
Glance View
Health House International Ltd. is an international distributor of medicinal cannabis. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-07-28. Its primary activities include operations in the pharmaceutical wholesale and distribution sectors. The company has two operating subsidiaries: Health House Pharma Limited, an international pharmaceutical distribution business in the United Kingdom and Health House International Pty Limited, a medicinal cannabis distribution business in Australia. Th products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is patented sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. The company distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12. The company also distributes products of various companies, such as Satipharm, HAPA pharm, Ananda Hemp and Little Green Pharma.
See Also
What is Health House International Ltd's Free Cash Flow?
Free Cash Flow
-4.1m
AUD
Based on the financial report for Jun 30, 2022, Health House International Ltd's Free Cash Flow amounts to -4.1m AUD.
What is Health House International Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-3%
Over the last year, the Free Cash Flow growth was -67%. The average annual Free Cash Flow growth rates for Health House International Ltd have been -32% over the past three years , -3% over the past five years .
